Serotonin transporter gene is not associated with symptomatology of schizophrenia

Schizophr Res. 1999 Jan 4;35(1):33-9. doi: 10.1016/s0920-9964(98)00111-x.

Abstract

The serotonin transporter gene is a primary candidate for involvement in major psychoses. A functional polymorphism in the upstream regulatory region of the serotonin transporter gene (5-HTTLPR) has recently been reported to be associated with a variety of psychopathological conditions. In the present study, we investigated the potential influence of the 5-HTTLPR on the psychopathology of schizophrenia. One hundred and sixty-one inpatients affected by schizophrenia (DSMIII-R) were assessed by the Operational Criteria checklist for psychotic illness (OPCRIT) and were typed for their 5-HTTLPR variants by PCR techniques. Mania, Depression, Delusion and Disorganization were the four symptomatologic factors used to define phenotype. 5-HTTLPR variants were not associated with these symptomatologic factors, and consideration of possible stratification effects such as sex, and age of onset did not reveal any association either. The serotonin transporter gene is not a liability factor for the symptomatology of schizophrenia.

MeSH terms

  • Adult
  • Carrier Proteins / genetics*
  • DNA Primers / genetics
  • Female
  • Genotype
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins*
  • Middle Aged
  • Nerve Tissue Proteins*
  • Phenotype
  • Polymorphism, Genetic / genetics
  • Schizophrenia / genetics*
  • Serotonin / genetics*
  • Serotonin Plasma Membrane Transport Proteins

Substances

  • Carrier Proteins
  • DNA Primers
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin